Zynex Return on Investment 2010-2025 | ZYXI
Current and historical return on investment (ROI) values for Zynex (ZYXI) over the last 10 years.
| Zynex ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-03-31 | $-0.01B | $0.08B | -8.86% |
| 2024-12-31 | $0.01B | $0.10B | 6.45% |
| 2024-09-30 | $0.01B | $0.10B | 9.45% |
| 2024-06-30 | $0.01B | $0.09B | 9.95% |
| 2024-03-31 | $0.01B | $0.09B | 10.21% |
| 2023-12-31 | $0.01B | $0.10B | 9.78% |
| 2023-09-30 | $0.02B | $0.12B | 19.10% |
| 2023-06-30 | $0.02B | $0.12B | 24.02% |
| 2023-03-31 | $0.02B | $0.07B | 28.97% |
| 2022-12-31 | $0.02B | $0.07B | 30.07% |
| 2022-09-30 | $0.03B | $0.07B | 31.35% |
| 2022-06-30 | $0.03B | $0.08B | 33.44% |
| 2022-03-31 | $0.03B | $0.09B | 35.62% |
| 2021-12-31 | $0.02B | $0.09B | 34.85% |
| 2021-09-30 | $0.01B | $0.06B | 22.03% |
| 2021-06-30 | $0.01B | $0.06B | 10.62% |
| 2021-03-31 | $0.01B | $0.06B | 12.31% |
| 2020-12-31 | $0.01B | $0.06B | 22.36% |
| 2020-09-30 | $0.01B | $0.05B | 35.48% |
| 2020-06-30 | $0.01B | $0.03B | 55.17% |
| 2020-03-31 | $0.01B | $0.02B | 59.46% |
| 2019-12-31 | $0.01B | $0.02B | 69.84% |
| 2019-09-30 | $0.01B | $0.02B | 76.92% |
| 2019-06-30 | $0.01B | $0.01B | 125.71% |
| 2019-03-31 | $0.01B | $0.01B | 209.52% |
| 2018-12-31 | $0.01B | $0.01B | 488.89% |
| 2018-09-30 | $0.01B | 0.00% | |
| 2018-06-30 | $0.01B | 2400.00% | |
| 2018-03-31 | $0.01B | 0.00% | |
| 2017-12-31 | $0.01B | -1200.00% | |
| 2017-09-30 | $0.01B | $0.00B | -342.86% |
| 2017-06-30 | $0.00B | $0.00B | -123.08% |
| 2017-03-31 | $0.00B | $0.00B | -53.33% |
| 2016-12-31 | $0.00B | $0.00B | -50.00% |
| 2016-09-30 | $0.00B | $0.00B | 0.00% |
| 2016-06-30 | $0.00B | $0.00B | 26.67% |
| 2016-03-31 | $0.00B | $0.00B | 30.77% |
| 2015-12-31 | $0.00B | $0.00B | 72.73% |
| 2015-09-30 | $0.00B | $0.00B | 0.00% |
| 2015-06-30 | $0.00B | $0.00B | 0.00% |
| 2015-03-31 | $-0.01B | $0.00B | 285.71% |
| 2014-12-31 | $-0.01B | $0.00B | 2000.00% |
| 2014-09-30 | $-0.01B | $0.00B | -800.00% |
| 2014-06-30 | $-0.01B | $0.00B | -275.00% |
| 2014-03-31 | $-0.01B | $0.00B | -128.57% |
| 2013-12-31 | $-0.01B | $0.01B | -88.89% |
| 2013-09-30 | $0.00B | $0.01B | -27.91% |
| 2013-06-30 | $0.00B | $0.01B | -8.70% |
| 2013-03-31 | $0.00B | $0.01B | 25.53% |
| 2012-12-31 | $0.00B | $0.01B | 26.09% |
| 2012-09-30 | $0.00B | $0.01B | 27.27% |
| 2012-06-30 | $0.00B | $0.01B | 28.57% |
| 2012-03-31 | $0.00B | $0.01B | 30.00% |
| 2011-12-31 | $0.00B | $0.01B | 32.43% |
| 2011-09-30 | $0.00B | $0.01B | 33.33% |
| 2011-06-30 | $0.00B | $0.01B | 35.29% |
| 2011-03-31 | $0.00B | $0.01B | 24.24% |
| 2010-12-31 | $0.00B | $0.01B | 24.24% |
| 2010-09-30 | $0.00B | $0.01B | 16.67% |
| 2010-06-30 | $0.00B | $0.01B | 17.39% |
| 2010-03-31 | $0.00B | $0.01B | 38.10% |
| 2009-12-31 | $0.00B | 66.67% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.072B | $0.192B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.781B | 27.87 |
| Boston Scientific (BSX) | United States | $152.324B | 38.13 |
| Stryker (SYK) | United States | $149.641B | 31.29 |
| EssilorLuxottica (ESLOY) | France | $137.721B | 0.00 |
| Medtronic (MDT) | Ireland | $114.146B | 16.18 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.237B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| ResMed (RMD) | United States | $37.534B | 28.19 |
| GE HealthCare Technologies (GEHC) | United States | $34.575B | 16.42 |
| Agilent Technologies (A) | United States | $34.457B | 22.46 |
| Terumo (TRUMY) | Japan | $25.051B | 32.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.235B | 16.30 |
| Insulet (PODD) | United States | $20.934B | 82.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.835B | 12.10 |
| Baxter (BAX) | United States | $15.298B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.441B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.887B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.776B | 14.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.897B | 17.41 |
| Perrigo (PRGO) | Ireland | $3.742B | 9.48 |
| Haemonetics (HAE) | United States | $3.724B | 16.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.454B | 28.70 |
| ICU Medical (ICUI) | United States | $3.341B | 24.63 |
| QuidelOrtho (QDEL) | United States | $2.135B | 14.68 |
| LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
| AtriCure (ATRC) | United States | $1.580B | 0.00 |
| Acuren (TIC) | United States | $1.397B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.272B | 16.26 |
| Green Thumb Industries (GTBIF) | United States | $1.249B | 28.09 |
| AdaptHealth (AHCO) | United States | $1.247B | 12.66 |
| Neogen (NEOG) | United States | $1.194B | 15.28 |
| BioLife Solutions (BLFS) | United States | $1.068B | 0.00 |
| InMode (INMD) | Israel | $0.963B | 9.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.791B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.679B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.53 |
| Evolus (EOLS) | United States | $0.623B | 0.00 |
| CeriBell (CBLL) | United States | $0.596B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.522B | 0.00 |
| Valneva SE (VALN) | France | $0.502B | 0.00 |
| Surmodics (SRDX) | United States | $0.441B | 0.00 |
| SNDL (SNDL) | Canada | $0.373B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Sanuwave Health (SNWV) | United States | $0.308B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.295B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.264B | 12.01 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 76.17 |
| Brainsway (BWAY) | Israel | $0.246B | 65.00 |
| Canopy Growth (CGC) | Canada | $0.232B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.15 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.126B | 15.53 |
| TerrAscend (TSNDF) | Canada | $0.104B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 53.29 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.82 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |